- Treatment of chronic active antibody-mediated rejection in kidney transplant patients: a systematic review
-
Go FR, Pamugas GE
- KMID: 2535125
- Korean J Transplant.
- 2022 Nov;36(Supple 1):S9.
- doi: 10.4285/ATW2022.F-0801
Background: Chronic antibody-mediated rejection (cAMR) is a major cause of graft dysfunction, graft loss and mortality in kidney transplantation. Variable treatment combinations have been used to treat cAMR but benefit... -
- CITED
-
- Close
- SHARE
-
- Close
- Low dose anti-thymocyte globulin versus basiliximab as induction in standard risk kidney transplant patients: 5-year follow-up
-
Cahilog C, Danguilan R, David PM, Arakama MH, Pamugas GE
- KMID: 2509195
- Korean J Transplant.
- 2020 Dec;34(Supple 1):S53.
- doi: 10.4285/ATW2020.OP-1026
Background: Kidney transplantation has significantly improved survival and quality of life of patients with end-stage renal disease and is considered the best form of renal replacement therapy. Rabbit anti-thymocyte globulin... -
- CITED
-
- Close
- SHARE
-
- Close
